Stay updated on Anti-PD-1 Monoclonal Antibody Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.

Latest updates to the Anti-PD-1 Monoclonal Antibody Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedLocations are consolidated under a single Locations section listing multiple Chinese regions (Beijing Municipality, Guangdong, Heilongjiang, Jiangsu, Jiangxi, Shanghai Municipality, Zhejiang). The HHS Vulnerability Disclosure link was removed and a new revision tag v3.3.3 was added.SummaryDifference0.8%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe Publications section text was updated to clarify that publications are auto-filled from PubMed and may not all pertain to the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoved the banner notice about a lapse in government funding and potential operating delays, including references to cc.nih.gov and opm.gov for updates.SummaryDifference0.4%

- Check60 days agoChange DetectedNo meaningful content changes detected. The page continues to display study details, eligibility criteria, and locations.SummaryDifference0.4%

- Check89 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, plus a version bump to v3.2.0; removes the old v3.1.0 reference.SummaryDifference3%

- Check96 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to Anti-PD-1 Monoclonal Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.